Pancreatic Cancer: How Cell Adaptation Impacts Treatment & Novel Approaches
A new study published February 16, 2026, in the journal Cell reveals a critical factor in the resilience of pancreatic cancer cells: their ability to adapt to their surroundings and switch between growth and survival modes. This adaptability is a key reason why pancreatic cancer is so hard to treat, and understanding it could unlock new therapeutic strategies.
The Role of Autophagy in Pancreatic Cancer Survival
Pancreatic cancer cells utilize a process called autophagy – essentially a “self-eating” mechanism where cells break down their own components for nutrients – to survive under stressful conditions, such as during chemotherapy. When autophagy is activated, cancer cells prioritize survival over rapid division, making them less susceptible to treatments designed to target swift-growing cells. Conversely, when autophagy is low, cells multiply more quickly.
The Extracellular Matrix and Autophagy Regulation
Researchers at NYU Langone Health discovered that a major determinant of autophagy levels in pancreatic cancer cells is their interaction with the extracellular matrix (ECM), the network of fibers surrounding cancer cells within a tumor. Cancer cells that are firmly anchored to the ECM exhibit lower levels of autophagy and a higher growth rate. However, cells that are more distant from the ECM increase autophagy, effectively entering a survival mode that protects them from chemotherapy 1.
Integrinα3: A Key Sensor of the ECM
The study identified integrin subunit α3 (integrinα3), a protein on the surface of cancer cells, as a key detector of specific ECM structural proteins, such as laminin. This detection process allows cancer cells to sense their environment and adjust their autophagy levels accordingly 1.
Implications for Treatment Strategies
The research suggests that current strategies designed to block autophagy may be limited in their effectiveness because cancer cells can adapt. The study authors found that genetically suppressing integrinα3 forced nearly all cancer cells into a high-autophagy mode, making autophagy-interfering drugs, like hydroxychloroquine, significantly more effective at killing them. Removing integrinα3 led to a 50% reduction in cancer cell survival compared to hydroxychloroquine alone 1.
inhibiting the protein NF2, which hinders the integrinα3 signal, also reduced autophagy and slowed lysosomal function – another critical survival pathway for cancer cells – leading to reduced tumor growth and cancer cell death 1.
Future Directions
The researchers propose that targeting both the ECM-mediated regulation of autophagy levels and lysosomal function may provide more durable antitumor responses. This research highlights the importance of considering the tumor microenvironment when developing new treatments for pancreatic cancer, a disease projected to become the second leading cause of cancer death in the United States 3.
This study was funded by National Cancer Institute grants P30CA016087, R37CA289040, P01CA117969, R35CA232124, P30CA016087-38, and 1R01CA251726-01A1, as well as the Damon Runyon Cancer Research Foundation, the Lustgarten Foundation, and Stand Up to Cancer 1.